Generic Drug News and Research

RSS
Generic Drugs are official nonbrand names by which medicines are known. Generic names usually refer to the chemical name of the drug.
IPS examines generic drug scheme in India's Rajasthan state

IPS examines generic drug scheme in India's Rajasthan state

Teva announces additional data from QNASL Phase III program on seasonal allergic rhinitis

Teva announces additional data from QNASL Phase III program on seasonal allergic rhinitis

BioXpress, AET BioTech enter agreement to co-develop Adalimumab biosimilar

BioXpress, AET BioTech enter agreement to co-develop Adalimumab biosimilar

Research roundup: Patients' unrealistic expectations for chemo; Neighborhood may affect CPR rates; Rate hike reviews working

Research roundup: Patients' unrealistic expectations for chemo; Neighborhood may affect CPR rates; Rate hike reviews working

Mexiletine improves patient-reported stiffness in nondystrophic myotonia

Mexiletine improves patient-reported stiffness in nondystrophic myotonia

Teva concludes Asset Transfer Agreement with NeuroSearch

Teva concludes Asset Transfer Agreement with NeuroSearch

Challenges to India's role as global pharmaceutical supplier

Challenges to India's role as global pharmaceutical supplier

Chronic respiratory disease treatments: an interview with Dr Sven Jan-Anders Karlsson, CEO of Verona Pharma

Chronic respiratory disease treatments: an interview with Dr Sven Jan-Anders Karlsson, CEO of Verona Pharma

CIRT to determine whether methotrexate can reduce heart attacks, strokes and CVD deaths

CIRT to determine whether methotrexate can reduce heart attacks, strokes and CVD deaths

Thiabendazole drug slows tumor growth and shows promise as chemotherapy for cancer

Thiabendazole drug slows tumor growth and shows promise as chemotherapy for cancer

Teva launches generic ACTOplus met to improve glucose control in adults with type 2 diabetes

Teva launches generic ACTOplus met to improve glucose control in adults with type 2 diabetes

FDA accepts Teva's NDA for Quartette oral contraceptive

FDA accepts Teva's NDA for Quartette oral contraceptive

Active Biotech, Teva to commence third Phase III study of laquinimod for RRMS

Active Biotech, Teva to commence third Phase III study of laquinimod for RRMS

Mylan launches 18 antiretroviral products in India to treat HIV/AIDS

Mylan launches 18 antiretroviral products in India to treat HIV/AIDS

Generic drugs saved U.S. $1T over 10 years, industry study finds

Generic drugs saved U.S. $1T over 10 years, industry study finds

Confrontation looms for big pharmaceutical companies, generic drug makers

Confrontation looms for big pharmaceutical companies, generic drug makers

First Edition: July 27, 2012

First Edition: July 27, 2012

Burgess to offer legislation to fund high-risk pools, reinsurance programs

Burgess to offer legislation to fund high-risk pools, reinsurance programs

First Edition: July 24, 2012

First Edition: July 24, 2012

Research roundup: Medication adherence, performance at community health centers

Research roundup: Medication adherence, performance at community health centers